Showing results (51-60 of 88) with videos related to
Sort By:
Pageof 9
The British Journal of Ophthalmology|August 25, 2001
Evaluation of potential organ culture media for eye banking using human donor corneasT Møller-Pedersen, U Hartmann, H J Møller, et al.Experimental Cell Research|September 1, 1995
The role of exogenous/endogenous basic fibroblast growth factor (FGF2) and transforming growth factor beta (TGF beta-1) on human corneal endothelial cells proliferation in vitroP Rieck, L Oliver, K Engelmann, et al.Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|January 6, 2001
[Percutaneous transvenous recovery of foreign bodies using a self-made wire loop]A Thalhammer, V Jacobi, J Balzer, et al.Klinische Monatsblatter Fur Augenheilkunde|June 8, 2001
[Early clinical results with mycophenolate mofetil in immunosuppressive therapy of ocular pemphigoid]J Zurdel, B Aboalchamat, M Zierhut, et al.Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|June 1, 1996
[HLA typing of donor corneas with extended post mortem time]A C Ventura, M Böhnke, C Löliger, et al.Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|October 12, 2002
[Rheophoresis. A systematic approach to therapy of age-related macular degeneration (AMD)?]A J Fell, K Engelmann, G Richard, et al.Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|August 9, 2001
[Immunosuppressive therapy with mycophenolate mofetil (CellCept) in treatment of uveitis]M Zierhut, N Stübiger, W Aboalchamat, et al.Klinische Monatsblatter Fur Augenheilkunde|March 31, 2004
[Intraocular epithelial downgrowth - report on 14 cases from 1986 to 2000]A Bangert, A A Bialasiewicz, K Engelmann, et al.Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|April 12, 2003
[Pathogenesis of choroidal neovascularization. Old concepts, new questions]S Fauser, K Engelmann, T U Krohne, et al.Der Radiologe|October 20, 1999
[Interventional MR-guided laser induced thermotherapy in oncologic indications. Status and prospects]T J Vogl, M G Mack, R Straub, et al.Pageof 9